We use cookies on this site in order to make it works, and for the traffic analysis.
You can refuse or configure cookies by purposes.
Another message from the Google Adsense consent management platform will ask you for your choices relating to the use of your personal data via cookies for advertising.
We thank you to accept cookies which makes this site work.

ESCMID-LeishMan VL questionnaire on the management of VL in Europe

mandatory answer

Question 1

Thank you to enter here your pseudonym

Question 2

Identification
You work in :

Comments

Question 3

Please specify your location : City and Country

Question 4

There is a reference centor for leishmaniasis in your country :

Comments

Question 5

Your volume of analysis, please specify on an annual basis :

Comments

Question 6

Among these samples types, which one are possibly processed in your lab :

Comments

Question 7

Among these samples types, which one are possibly processed in your lab for direct examination and/or culture :

Comments

Question 8

Among these samples types, which one is recommended in first-line for the diagnosis of VL in your hospital :

Comments

Question 9

Direct examination is :

Comments

Question 10

Diagnosis Tools :
Direct examination is performed :

Comments

Question 11

Culture of Leishmania is :

Comments

Question 12

Culture is performed using (*supplemented with fetal calf serum +/- antibiotics) :

Comments

Question 13

Serology tests are :

Comments

Question 14

Serology is performed using :

Comments

Question 15

Molecular detection is

Comments

Question 16

Molecular detection is performed using :

Comments

Question 17

Targets of the primers for PCR available in your lab are :

Comments

Question 18

Identification of Leishmania is performed using :

Comments

Question 19

Targets for the sequencing available in your lab are :

Comments

Question 20

Drugs available in your hospital for the treatment of VL are :

Comments

Question 21

The first-line treatment in adults is :

Comments

Question 22

The second-line treatment in adults is :

Comments

Question 23

The first-line treatment in children is :

Comments

Question 24

The second-line treatment in children is :

Comments

Question 25

When using liposomal Amphotericin B (Ambisome), please specify the total dose and administration schedule for :

Comments

Question 26

Do you perform in vitro sensitivity testing of Leishmania isolates in your lab :

Comments

Question 27

Do you think that in vitro sensitivity testing of Leishmania would be helpful for the choice of the drug :

Comments

Question 28

Do you use pharmacological drug monitoring in your hospital :

Comments

Question 29

Do you think that pharmacological drug monitoring would be helpful for the choice of the drug :

Comments

Question 30

At what term do you consider that the VL treatment succeeded of failed and on what sample :

Comments

Question 31

The first-line treatment for secondary prophylaxis in adults is :

Comments

Question 32

The first-line treatment for secondary prophylaxis in children is :

Comments

Question 33

When using liposomal Amphotericin B (Ambisome) for secondary prophylaxis, please specify the dose and administration schedule :

Question 34

When using another drug for secondary prophylaxis, please specify the dose and administration schedule :




You too, create your online questionnaire!
It's free and easy.
Let's go!